14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $18.05 $25.50 Thursday, 2nd May 2024 PHVS stock ended at $23.53. This is 4.23% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 8.56% from a day low at $23.49 to a day high of $25.50.
90 days $18.05 $33.00
52 weeks $7.93 $33.00

Historical Pharvaris B.V. prices

Date Open High Low Close Volume
Sep 27, 2023 $20.53 $21.26 $20.12 $21.26 36 206
Sep 26, 2023 $20.54 $20.62 $20.12 $20.61 19 843
Sep 25, 2023 $20.74 $21.51 $20.10 $20.67 35 256
Sep 22, 2023 $20.13 $20.70 $19.86 $20.32 19 608
Sep 21, 2023 $19.07 $20.30 $18.89 $19.78 30 316
Sep 20, 2023 $21.20 $21.46 $18.85 $19.55 26 683
Sep 19, 2023 $18.40 $21.97 $18.40 $21.40 53 467
Sep 18, 2023 $20.05 $20.47 $18.34 $18.34 30 440
Sep 15, 2023 $20.56 $20.95 $20.25 $20.25 22 345
Sep 14, 2023 $20.39 $20.98 $20.13 $20.62 11 344
Sep 13, 2023 $19.51 $20.61 $19.26 $20.61 12 807
Sep 12, 2023 $19.64 $20.27 $19.25 $19.85 69 055
Sep 11, 2023 $20.91 $20.91 $19.12 $19.60 35 263
Sep 08, 2023 $19.37 $21.69 $19.24 $21.22 30 839
Sep 07, 2023 $20.67 $21.25 $18.60 $19.00 68 303
Sep 06, 2023 $20.66 $23.66 $20.66 $21.00 110 971
Sep 05, 2023 $20.96 $21.46 $20.22 $21.00 127 558
Sep 01, 2023 $20.64 $21.54 $20.20 $21.32 78 712
Aug 31, 2023 $19.64 $20.60 $19.18 $20.50 32 424
Aug 30, 2023 $19.37 $20.00 $19.11 $19.91 13 956
Aug 29, 2023 $19.06 $19.76 $18.80 $19.40 17 633
Aug 28, 2023 $18.61 $19.57 $18.61 $18.77 47 883
Aug 25, 2023 $18.46 $19.31 $18.25 $19.27 11 086
Aug 24, 2023 $19.89 $20.10 $18.67 $18.67 20 782
Aug 23, 2023 $20.14 $20.44 $19.08 $20.00 39 706
Click to get the best stock tips daily for free!

About Pharvaris B.V.

Pharvaris B.V. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical ... PHVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT